Literature DB >> 38071

Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method.

C G Dahlöf, P Lundborg, B A Persson, C G Regårdh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 38071

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  9 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

3.  Comparison of single and divided daily dose spironolactone in the control of hypertension.

Authors:  G M Bell; L Fananapazir; J L Anderton
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

4.  A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.

Authors:  D L Murdoch; G Forrest; D L Davies; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

5.  Improved bioavailability from a spironolactone beta-cyclodextrin complex.

Authors:  N T Yusuff; P York; H Chrystyn; P N Bramley; R D Swallow; B R Tuladhar; M S Losowsky
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Endocrine and clinical effects of spironolactone in female hyperandrogenism.

Authors:  R Siegberg; P Ylöstalo; T Laatikainen; R Pelkonen; U H Stenman
Journal:  Arch Gynecol       Date:  1987

7.  Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man.

Authors:  W Krause; J Karras; W Seifert
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone.

Authors:  P C Ho; D W Bourne; E J Triggs; V Heazlewood
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.

Authors:  Peter Kolkhof; Lars Bärfacker
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.